The primary outcome was the proportion of patients with excellent outcome ( ie , an mRS score of @-@ , or @ if premorbid score was @ ) at @ days , analysed in the target population ( all randomly assigned patients who had been correctly diagnosed with ischaemic stroke and had begun study medication ) .